AI assistant
Sending…
COGNITION THERAPEUTICS INC — Director's Dealing 2021
Nov 10, 2021
34027_dirs_2021-11-10_30c95e15-5dbd-459a-8f94-77df00caae57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COGNITION THERAPEUTICS INC (CGTX)
CIK: 0001455365
Period of Report: 2021-11-01
Reporting Person: Caggiano Anthony (Chief Medical Officer)
More from COGNITION THERAPEUTICS INC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
Mar 26
Annual Report
2026
Mar 26
Earnings Release
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 5